| Pharmaceutical active ingredients: |
| Mitoxantrone Hydrochloride |
| Available forms, composition and doses of Mitaxis: |
| N / A |
| Mitaxis medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01DB07 - Mitoxantrone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Itaca Laboratorios |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Elsep | Mitoxantrone Hydrochloride | Wyeth; Meda |
| Formyxan | Mitoxantrone Hydrochloride | Pisa Laboratorios |
| Genefadrone | Mitoxantrone Hydrochloride | Genepharma Group |
| Micraleve | Mitoxantrone Hydrochloride | IVAX |
| Misostol | Mitoxantrone Hydrochloride | Zodiac Produtos Farmaceuticos |
| Mitoxal | Mitoxantrone Hydrochloride | Asta Medica |
| Mitoxan | Mitoxantrone Hydrochloride | ADiPharm |
| Mitoxantron | Mitoxantrone Hydrochloride | Ebewe; Firma Vai Hong; Sandoz; Zuellig Pharma |
| Mitoxantrona | Mitoxantrone Hydrochloride | Baxter |
| Mitoxantrone | Mitoxantrone Hydrochloride | APP Pharmaceuticals |